Yousef, Nadya
Singh, Yogen
De Luca, Daniele
Article History
Received: 25 February 2021
Revised: 26 May 2021
Accepted: 24 June 2021
First Online: 5 July 2021
Declarations
:
: Dr. Yousef and A/Prof. De Luca have received grants and honoraria from Chiesi Pharmaceuticals. Dr. Yousef and A/Prof. De Luca have served as consultants and lecturers for Chiesi Pharmaceuticals. A/Prof. De Luca has been a member of the advisory board for Chiesi Pharmaceuticals. A/Prof. De Luca has received grants from and been an advisory board member of AbbVie and served as consultant and lecturer for Airway Therapeutics and AbbVie. These companies have had no role in the design, preparation, review, or approval of the manuscript or the decision to submit it for publication. Dr. Singh has served as a lecturer and received honorarium from AbbVie, Orphan Europe / Rorcordati Rare Diseases UK. He is Chair of Data and Safety Monitoring Board (DSMB) for a research project funded by GE. These companies have had no role in the design, preparation, review, or approval of the manuscript or the decision to submit it for publication.
Free to read: This content has been made available to all.